Detalles de la búsqueda
1.
Truncated O-GalNAc glycans impact on fundamental signaling pathways in pancreatic cancer.
Glycobiology;
2021 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34420045
2.
Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ).
Clin Oral Investig;
25(5): 2801-2809, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33006027
3.
Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)-An In Vivo Animal Trial.
Int J Mol Sci;
22(1)2021 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33466246
4.
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo.
Int J Mol Sci;
21(4)2020 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32102484
5.
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
BMC Cancer;
17(1): 60, 2017 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100188
6.
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Mol Cancer;
14: 109, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021314
7.
Ibrutinib (ImbruvicaTM) potently inhibits ErbB receptor phosphorylation and cell viability of ErbB2-positive breast cancer cells.
Invest New Drugs;
32(6): 1096-104, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25081321
8.
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors.
Invest New Drugs;
32(6): 1144-54, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25152244
9.
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Int J Cancer;
133(9): 2065-76, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23588885
10.
Tumor cell integrin ß4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo.
J Hematol Oncol;
16(1): 23, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36932441
11.
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
Mol Cancer;
11: 85, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23167739
12.
A Critical Role of the IL-22-IL-22 Binding Protein Axis in Hepatocellular Carcinoma.
Cancers (Basel);
14(24)2022 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551508
13.
Ectopic Expression of Hematopoietic SHIP1 in Human Colorectal Cancer.
Biomedicines;
8(7)2020 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32679836
14.
Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Clin Exp Metastasis;
37(6): 649-656, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33099724
15.
Evaluation of Periodontal Space Widening in Patients with Antiresorptive Drug-related Osteonecrosis of the Jaws (ARONJ) on Panoramic Radiographs.
Anticancer Res;
38(9): 5305-5314, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194182
16.
Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.
Oncotarget;
8(52): 89978-89987, 2017 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29163804
17.
Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit.
World J Gastrointest Surg;
8(2): 124-33, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26981186
18.
Extracellular-signal regulated kinase (Erk1/2), mitogen-activated protein kinase-activated protein kinase 2 (MK2) and tristetraprolin (TTP) comprehensively regulate injury-induced immediate early gene (IEG) response in in vitro liver organ culture.
Cell Signal;
28(5): 438-447, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26876787
19.
Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
PLoS One;
11(1): e0146370, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26741489
20.
Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Cell Signal;
28(12): 1872-1880, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27619201